Last update 01 Nov 2024

CaN x PPIB x GR

Basic Info

Related Targets
CaNPPIBGR

Related

1
Drugs associated with CaN x PPIB x GR
Ciclosporin/Prednisolone
Target
CaN x GR x PPIB
Mechanism
CaN inhibitors [+3]
Active Org.-
Originator Org.
CombinatoRx, Inc.CombinatoRx, Inc.
Active Indication-
Inactive Indication
Conjunctivitis, Allergic [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CaN x PPIB x GR
NCT00833495 / CompletedPhase 2
A Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Co-Administration of FOV1101-00 (Cyclosporine 0.01% or 0.02%) and Prednisolone Acetate 0.12% (PredMild®) Compared to Prednisolone Acetate 1% Alone or Vehicle Alone in Patients With Mild Ongoing Ocular Allergic Inflammation
100 Clinical Results associated with CaN x PPIB x GR
Login to view more data
100 Translational Medicine associated with CaN x PPIB x GR
Login to view more data
0 Patents (Medical) associated with CaN x PPIB x GR
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free